Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 76

1.

Possible net harms of breast cancer screening: updated modelling of Forrest report.

Raftery J, Chorozoglou M.

BMJ. 2011 Dec 8;343:d7627. doi: 10.1136/bmj.d7627.

2.

Retrospective cost-effectiveness analysis of screening mammography.

Stout NK, Rosenberg MA, Trentham-Dietz A, Smith MA, Robinson SM, Fryback DG.

J Natl Cancer Inst. 2006 Jun 7;98(11):774-82.

PMID:
16757702
3.

Swiss Medical Board Mammography screening predictions for Switzerland: importance of time-periods.

de Koning HJ, Heijnsdijk EA.

J Med Screen. 2015 Dec;22(4):201-6. doi: 10.1177/0969141315586639. Epub 2015 May 27.

PMID:
26018779
4.

Benefits and harms of mammography screening after age 74 years: model estimates of overdiagnosis.

van Ravesteyn NT, Stout NK, Schechter CB, Heijnsdijk EA, Alagoz O, Trentham-Dietz A, Mandelblatt JS, de Koning HJ.

J Natl Cancer Inst. 2015 May 6;107(7). pii: djv103. doi: 10.1093/jnci/djv103. Print 2015 Jul.

5.

Personalizing mammography by breast density and other risk factors for breast cancer: analysis of health benefits and cost-effectiveness.

Schousboe JT, Kerlikowske K, Loh A, Cummings SR.

Ann Intern Med. 2011 Jul 5;155(1):10-20. doi: 10.7326/0003-4819-155-1-201107050-00003.

6.

Screening for breast cancer with mammography.

Gøtzsche PC, Nielsen M.

Cochrane Database Syst Rev. 2006 Oct 18;(4):CD001877. Review. Update in: Cochrane Database Syst Rev. 2009;(4):CD001877.

PMID:
17054145
7.

Preventive health care, 2001 update: screening mammography among women aged 40-49 years at average risk of breast cancer.

Ringash J; Canadian Task Force on Preventive Health Care.

CMAJ. 2001 Feb 20;164(4):469-76. Review. Erratum in: CMAJ 2001 Mar 20;164(6):753.

8.

Tipping the balance of benefits and harms to favor screening mammography starting at age 40 years: a comparative modeling study of risk.

van Ravesteyn NT, Miglioretti DL, Stout NK, Lee SJ, Schechter CB, Buist DS, Huang H, Heijnsdijk EA, Trentham-Dietz A, Alagoz O, Near AM, Kerlikowske K, Nelson HD, Mandelblatt JS, de Koning HJ.

Ann Intern Med. 2012 May 1;156(9):609-17. doi: 10.7326/0003-4819-156-9-201205010-00002.

9.

Systematic review of the psychological consequences of false-positive screening mammograms.

Bond M, Pavey T, Welch K, Cooper C, Garside R, Dean S, Hyde C.

Health Technol Assess. 2013 Mar;17(13):1-170, v-vi. doi: 10.3310/hta17130. Review.

10.
11.

Screening for breast cancer with mammography.

Gøtzsche PC, Nielsen M.

Cochrane Database Syst Rev. 2011 Jan 19;(1):CD001877. doi: 10.1002/14651858.CD001877.pub4. Review. Update in: Cochrane Database Syst Rev. 2013;6:CD001877.

PMID:
21249649
12.

Screening for breast cancer with mammography.

Gøtzsche PC, Nielsen M.

Cochrane Database Syst Rev. 2009 Oct 7;(4):CD001877. doi: 10.1002/14651858.CD001877.pub3. Review. Update in: Cochrane Database Syst Rev. 2011;(1):CD001877.

PMID:
19821284
13.

Screening mammography for women aged 40 to 49 years at average risk for breast cancer: an evidence-based analysis.

Health Quality Ontario.

Ont Health Technol Assess Ser. 2007;7(1):1-32. Epub 2007 Jan 1.

14.

Benefits, harms, and costs for breast cancer screening after US implementation of digital mammography.

Stout NK, Lee SJ, Schechter CB, Kerlikowske K, Alagoz O, Berry D, Buist DS, Cevik M, Chisholm G, de Koning HJ, Huang H, Hubbard RA, Miglioretti DL, Munsell MF, Trentham-Dietz A, van Ravesteyn NT, Tosteson AN, Mandelblatt JS.

J Natl Cancer Inst. 2014 May 28;106(6):dju092. doi: 10.1093/jnci/dju092. Print 2014 Jun.

15.

Supplemental Screening for Breast Cancer in Women With Dense Breasts: A Systematic Review for the U.S. Preventive Service Task Force [Internet].

Melnikow J, Fenton JJ, Whitlock EP, Miglioretti DL, Weyrich MS, Thompson JH, Shah K.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2016 Jan.

16.

A systematic assessment of benefits and risks to guide breast cancer screening decisions.

Pace LE, Keating NL.

JAMA. 2014 Apr 2;311(13):1327-35. doi: 10.1001/jama.2014.1398. Review.

PMID:
24691608
17.

The clinical effectiveness and cost-effectiveness of different surveillance mammography regimens after the treatment for primary breast cancer: systematic reviews registry database analyses and economic evaluation.

Robertson C, Arcot Ragupathy SK, Boachie C, Dixon JM, Fraser C, Hernández R, Heys S, Jack W, Kerr GR, Lawrence G, MacLennan G, Maxwell A, McGregor J, Mowatt G, Pinder S, Ternent L, Thomas RE, Vale L, Wilson R, Zhu S, Gilbert FJ.

Health Technol Assess. 2011 Sep;15(34):v-vi, 1-322. doi: 10.3310/hta15340. Review.

18.

Screening for breast cancer with mammography.

Gøtzsche PC, Jørgensen KJ.

Cochrane Database Syst Rev. 2013 Jun 4;(6):CD001877. doi: 10.1002/14651858.CD001877.pub5. Review.

19.

The benefits and harms of breast cancer screening: an independent review.

Independent UK Panel on Breast Cancer Screening.

Lancet. 2012 Nov 17;380(9855):1778-86. doi: 10.1016/S0140-6736(12)61611-0. Epub 2012 Oct 30. Review.

PMID:
23117178
20.

Screening mammography in older women: a review.

Walter LC, Schonberg MA.

JAMA. 2014 Apr 2;311(13):1336-47. doi: 10.1001/jama.2014.2834. Review.

Supplemental Content

Support Center